SGInnovate — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Lucencelucence.cominNov 2019 · $20M
Lucence develops blood-based diagnostic tests for early cancer detection, hereditary and health risk assessment, treatment selection, and treatment response monitoring.
AI & Machine LearningBiotechDigital HealthHealthtechLongevitySingapore, SG
Co-investorsOpenspace VenturesHeliconia Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.